Literature DB >> 7511590

Role of gamma 87 Gln in the inhibition of hemoglobin S polymerization by hemoglobin F.

K Adachi1, P Konitzer, S Surrey.   

Abstract

Previous studies suggested that gamma 87 Gln in hemoglobin (Hb) F is an important site for promoting inhibition of Hb S (alpha 2 beta 2(6 Glu-->Val) polymerization by Hb F. We engineered and isolated the double mutant (Hb alpha 2 beta 2(6 Glu-->Val,87 Thr-->Gln) using a yeast expression system and characterized polymerization properties of this modified tetramer in an effort to clarify the role of Gln at position 87 in inhibiting Hb S polymerization. Electrophoretic mobility and absorption spectra of this double mutant were the same as that of Hb S, while oxygen affinity was higher, and effects of organic phosphates on oxygen affinity were reduced. The deoxy form of the double mutant showed a characteristic delay time prior to polymerization in vitro. The critical concentration for polymerization of the double mutant was about 1.5 times higher than Hb S, and delay and polymerization times were much longer than Hb S at the same hemoglobin concentrations. The logarithmic plot of delay time versus hemoglobin concentration for the double mutant showed a straight line that was intermediate between lines for AS and FS mixtures. These results and those of kinetics of polymerization of Hb S/double mutant mixtures indicate that substitution of Gln for Thr at beta 87 in Hb S prolongs delay time and inhibits polymerization, although the double mutant forms polymers like Hb S.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Pair-wise interactions of polymerization inhibitory contact site mutations of hemoglobin-S.

Authors:  Sonati Srinivasulu; Krishnaveni Perumalsamy; Rajendra Upadhya; Belur N Manjula; Steven Feiring; Raouf Alami; Eric Bouhassira; Mary E Fabry; Ronald L Nagel; A Seetharama Acharya
Journal:  Protein J       Date:  2006-12       Impact factor: 2.371

2.  HbS-Savaria: the anti-polymerization effect of a single mutation in human alpha-chains.

Authors:  Sonati Srinivasulu; A Seetharama Acharya; Muthuchidambaran Prabhakaran; Mary E Fabry; Raouf Alami; Steven N Fiering; Eric E Bouhasirra; Ronald L Nagel
Journal:  Protein J       Date:  2007-12       Impact factor: 2.371

Review 3.  Gene therapy for sickle cell disease: An update.

Authors:  Selami Demirci; Naoya Uchida; John F Tisdale
Journal:  Cytotherapy       Date:  2018-05-30       Impact factor: 5.414

Review 4.  Gene Therapy for β-Hemoglobinopathies.

Authors:  Marina Cavazzana; Chiara Antoniani; Annarita Miccio
Journal:  Mol Ther       Date:  2017-04-01       Impact factor: 11.454

5.  Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility.

Authors:  Ming F Tam; Tsuey Chyi S Tam; Virgil Simplaceanu; Nancy T Ho; Ming Zou; Chien Ho
Journal:  J Biol Chem       Date:  2015-07-16       Impact factor: 5.157

6.  Mutational analysis of phenylalanine beta 85 in the valine beta 6 acceptor pocket during hemoglobin S polymerization.

Authors:  K Adachi; L R Reddy; K S Reddy; S Surrey
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

7.  The genetic basis and evolution of red blood cell sickling in deer.

Authors:  Alexander Esin; L Therese Bergendahl; Vincent Savolainen; Joseph A Marsh; Tobias Warnecke
Journal:  Nat Ecol Evol       Date:  2017-12-18       Impact factor: 15.460

8.  Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Authors:  Olivier Negre; Anne-Virginie Eggimann; Yves Beuzard; Jean-Antoine Ribeil; Philippe Bourget; Suparerk Borwornpinyo; Suradej Hongeng; Salima Hacein-Bey; Marina Cavazzana; Philippe Leboulch; Emmanuel Payen
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.